Literature DB >> 22891310

Retinal prosthetic strategy with the capacity to restore normal vision.

Sheila Nirenberg1, Chethan Pandarinath.   

Abstract

Retinal prosthetics offer hope for patients with retinal degenerative diseases. There are 20-25 million people worldwide who are blind or facing blindness due to these diseases, and they have few treatment options. Drug therapies are able to help a small fraction of the population, but for the vast majority, their best hope is through prosthetic devices [reviewed in Chader et al. (2009) Prog Brain Res 175:317-332]. Current prosthetics, however, are still very limited in the vision that they provide: for example, they allow for perception of spots of light and high-contrast edges, but not natural images. Efforts to improve prosthetic capabilities have focused largely on increasing the resolution of the device's stimulators (either electrodes or optogenetic transducers). Here, we show that a second factor is also critical: driving the stimulators with the retina's neural code. Using the mouse as a model system, we generated a prosthetic system that incorporates the code. This dramatically increased the system's capabilities--well beyond what can be achieved just by increasing resolution. Furthermore, the results show, using 9,800 optogenetically stimulated ganglion cell responses, that the combined effect of using the code and high-resolution stimulation is able to bring prosthetic capabilities into the realm of normal image representation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891310      PMCID: PMC3443127          DOI: 10.1073/pnas.1207035109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The negative ERG is not synonymous with nightblindness.

Authors:  G W Cibis; K M Fitzgerald
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells.

Authors:  Senthil Thyagarajan; Michiel van Wyk; Konrad Lehmann; Siegrid Löwel; Guoping Feng; Heinz Wässle
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

3.  Retinal ganglion cells projecting to the accessory optic system in the rat.

Authors:  J F Dann; E H Buhl
Journal:  J Comp Neurol       Date:  1987-08-01       Impact factor: 3.215

Review 4.  Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis.

Authors:  Gerald J Chader; James Weiland; Mark S Humayun
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

5.  Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism.

Authors:  Kenneth P Greenberg; Aaron Pham; Frank S Werblin
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

6.  Gene therapy for red-green colour blindness in adult primates.

Authors:  Katherine Mancuso; William W Hauswirth; Qiuhong Li; Thomas B Connor; James A Kuchenbecker; Matthew C Mauck; Jay Neitz; Maureen Neitz
Journal:  Nature       Date:  2009-09-16       Impact factor: 49.962

7.  Vision 1 year after gene therapy for Leber's congenital amaurosis.

Authors:  Artur V Cideciyan; William W Hauswirth; Tomas S Aleman; Shalesh Kaushal; Sharon B Schwartz; Sanford L Boye; Elizabeth A M Windsor; Thomas J Conlon; Alexander Sumaroka; Alejandro J Roman; Barry J Byrne; Samuel G Jacobson
Journal:  N Engl J Med       Date:  2009-08-13       Impact factor: 91.245

8.  Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.

Authors:  William W Hauswirth; Tomas S Aleman; Shalesh Kaushal; Artur V Cideciyan; Sharon B Schwartz; Lili Wang; Thomas J Conlon; Sanford L Boye; Terence R Flotte; Barry J Byrne; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2008-10       Impact factor: 5.695

9.  Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.

Authors:  Francesca Simonelli; Albert M Maguire; Francesco Testa; Eric A Pierce; Federico Mingozzi; Jeannette L Bennicelli; Settimio Rossi; Kathleen Marshall; Sandro Banfi; Enrico M Surace; Junwei Sun; T Michael Redmond; Xiaosong Zhu; Kenneth S Shindler; Gui-Shuang Ying; Carmela Ziviello; Carmela Acerra; J Fraser Wright; Jennifer Wellman McDonnell; Katherine A High; Jean Bennett; Alberto Auricchio
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

10.  Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter.

Authors:  Hiroshi Tomita; Eriko Sugano; Yugo Fukazawa; Hitomi Isago; Yuka Sugiyama; Teru Hiroi; Toru Ishizuka; Hajime Mushiake; Megumi Kato; Masumi Hirabayashi; Ryuichi Shigemoto; Hiromu Yawo; Makoto Tamai
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more
  68 in total

Review 1.  Pulse trains to percepts: the challenge of creating a perceptually intelligible world with sight recovery technologies.

Authors:  Ione Fine; Geoffrey M Boynton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

2.  Frequency spectrum might act as communication code between retina and visual cortex I.

Authors:  Xu Yang; Bo Gong; Jian-Wei Lu
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

3.  Optogenetic spatial and temporal control of cortical circuits on a columnar scale.

Authors:  Arani Roy; Jason J Osik; Neil J Ritter; Shen Wang; James T Shaw; József Fiser; Stephen D Van Hooser
Journal:  J Neurophysiol       Date:  2015-12-02       Impact factor: 2.714

4.  Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.

Authors:  Shannon E Boye; John J Alexander; C Douglas Witherspoon; Sanford L Boye; James J Peterson; Mark E Clark; Kristen J Sandefer; Chris A Girkin; William W Hauswirth; Paul D Gamlin
Journal:  Hum Gene Ther       Date:  2016-08       Impact factor: 5.695

5.  Interacting linear and nonlinear characteristics produce population coding asymmetries between ON and OFF cells in the retina.

Authors:  Zachary Nichols; Sheila Nirenberg; Jonathan Victor
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

6.  Mobile zinc increases rapidly in the retina after optic nerve injury and regulates ganglion cell survival and optic nerve regeneration.

Authors:  Yiqing Li; Lukas Andereggen; Kenya Yuki; Kumiko Omura; Yuqin Yin; Hui-Ya Gilbert; Burcu Erdogan; Maria S Asdourian; Christine Shrock; Silmara de Lima; Ulf-Peter Apfel; Yehong Zhuo; Michal Hershfinkel; Stephen J Lippard; Paul A Rosenberg; Larry Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

7.  Optogenetic Retinal Gene Therapy with the Light Gated GPCR Vertebrate Rhodopsin.

Authors:  Benjamin M Gaub; Michael H Berry; Meike Visel; Amy Holt; Ehud Y Isacoff; John G Flannery
Journal:  Methods Mol Biol       Date:  2018

8.  Chapter 2 - Restoring Vision to the Blind: Optogenetics.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

9.  Chapter 1 - Restoring Vision to the Blind: The New Age of Implanted Visual Prostheses.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

10.  Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells.

Authors:  Benjamin M Gaub; Michael H Berry; Amy E Holt; Andreas Reiner; Michael A Kienzler; Natalia Dolgova; Sergei Nikonov; Gustavo D Aguirre; William A Beltran; John G Flannery; Ehud Y Isacoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.